137 related articles for article (PubMed ID: 11328664)
101. Computer simulation of the blood-brain barrier: a model including two membranes, blood flow, facilitated and non-facilitated diffusion.
Oyler GA; Duckrow RB; Hawkins RA
J Neurosci Methods; 1992 Sep; 44(2-3):179-96. PubMed ID: 1474851
[TBL] [Abstract][Full Text] [Related]
102. All antihistamines cross blood-brain barrier.
Ramaekers JG; Vermeeren A
BMJ; 2000 Sep; 321(7260):572. PubMed ID: 11023307
[No Abstract] [Full Text] [Related]
103. Irradiation of the head by 60Co opens the blood-brain barrier for drugs in rats.
Bezek S; Trnovec T; Scasnár V; Durisová M; Kukan M; Kállay Z; Laginová V; Svoboda V
Experientia; 1990 Oct; 46(10):1017-20. PubMed ID: 2226715
[TBL] [Abstract][Full Text] [Related]
104. A large-scale electrophoresis- and chromatography-based determination of gene expression profiles in bovine brain capillary endothelial cells after the re-induction of blood-brain barrier properties.
Pottiez G; Deracinois B; Duban-Deweer S; Cecchelli R; Fenart L; Karamanos Y; Flahaut C
Proteome Sci; 2010 Nov; 8():57. PubMed ID: 21078152
[TBL] [Abstract][Full Text] [Related]
105. Transporter-Mediated Drug Delivery.
Gyimesi G; Hediger MA
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
[TBL] [Abstract][Full Text] [Related]
106. Improved Bioavailability of Ebastine through Development of Transfersomal Oral Films.
Islam N; Irfan M; Zahoor AF; Iqbal MS; Syed HK; Khan IU; Rasul A; Khan SU; Alqahtani AM; Ikram M; Abdul Qayyum M; Khames A; Inam S; Abourehab MAS
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452276
[TBL] [Abstract][Full Text] [Related]
107. Ebastine in the light of CONGA recommendations for the development of third-generation antihistamines.
Rico S; Antonijoan R; Barbanoj M
J Asthma Allergy; 2009 Aug; 2():73-92. PubMed ID: 21437146
[TBL] [Abstract][Full Text] [Related]
108. Peripheral and central H1 histamine receptor occupancy by levocetirizine, a non-sedating antihistamine; a time course study in the guinea pig.
Gupta A; Gillard M; Christophe B; Chatelain P; Massingham R; Hammarlund-Udenaes M
Br J Pharmacol; 2007 Aug; 151(7):1129-36. PubMed ID: 17558437
[TBL] [Abstract][Full Text] [Related]
109. The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 polymorphisms and gender on the urinary excretion of the metabolites of the H-receptor antihistamine ebastine: a pilot study.
Gervasini G; Vizcaino S; Carrillo JA; Caballero MJ; Benitez J
Br J Clin Pharmacol; 2006 Aug; 62(2):177-86. PubMed ID: 16842392
[TBL] [Abstract][Full Text] [Related]
110. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems.
Tsuji A
NeuroRx; 2005 Jan; 2(1):54-62. PubMed ID: 15717057
[TBL] [Abstract][Full Text] [Related]
111. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine.
Tagawa M; Kano M; Okamura N; Higuchi M; Matsuda M; Mizuki Y; Arai H; Iwata R; Fujii T; Komemushi S; Ido T; Itoh M; Sasaki H; Watanabe T; Yanai K
Br J Clin Pharmacol; 2001 Nov; 52(5):501-9. PubMed ID: 11736858
[TBL] [Abstract][Full Text] [Related]
112. Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.
Matsuda M; Sakashita M; Mizuki Y; Yamaguchi T; Fujii T; Sekine Y
Arzneimittelforschung; 1994 Jan; 44(1):55-9. PubMed ID: 7907872
[TBL] [Abstract][Full Text] [Related]
113. Functional expression and localization of P-glycoprotein at the blood brain barrier.
Bendayan R; Lee G; Bendayan M
Microsc Res Tech; 2002 Jun; 57(5):365-80. PubMed ID: 12112443
[TBL] [Abstract][Full Text] [Related]
114. A preclinical overview of ebastine. Studies on the pharmacological properties of a novel histamine H1 receptor antagonist.
Roberts DJ
Drugs; 1996; 52 Suppl 1():8-14. PubMed ID: 8828021
[TBL] [Abstract][Full Text] [Related]
115. Blood-brain barrier transport of H1-antagonist ebastine and its metabolite carebastine.
Tamai I; Kido Y; Yamashita J; Sai Y; Tsuji A
J Drug Target; 2000; 8(6):383-93. PubMed ID: 11328664
[TBL] [Abstract][Full Text] [Related]
116. Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier.
Murata M; Tamai I; Kato H; Nagata O; Tsuji A
J Pharmacol Exp Ther; 1999 Jul; 290(1):51-7. PubMed ID: 10381759
[TBL] [Abstract][Full Text] [Related]
117. Pharmacokinetics of the H1-receptor antagonist ebastine and its active metabolite carebastine in healthy subjects.
Yamaguchi T; Hashizume T; Matsuda M; Sakashita M; Fujii T; Sekine Y; Nakashima M; Uematsu T
Arzneimittelforschung; 1994 Jan; 44(1):59-64. PubMed ID: 7907873
[TBL] [Abstract][Full Text] [Related]
118.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
119.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
120.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
